Congress to Approve Cannabis

“Donald Trump wants to legalize marijuana. I know because he told me personally several times.” It seems as though politics have finally come around to cannabis. Outsider Club editor Jimmy Mengel discusses the future of legal cannabis and how investors can reap the rewards... You are receiving this email because you subscribed to Outsider Club. [Click here]( to manage your e-mail preferences. [Outsider Club logo] Congress to Approve Cannabis [Jimmy Mengel Photo] By [Jimmy Mengel]( Written Feb. 28, 2019 “Donald Trump wants to legalize marijuana. I know because he told me personally several times.” That was what Republican Rep. Dana Rohrabacher from California told me this week, over drinks in Medellín, Colombia (why I was in Colombia is a story for another time). [dana] *Editors note: When interviewing Congressmen, a few drinks in a foreign locale are helpful. And Rep. Rohrabacher should know — not only was he on the short list for Secretary of State for President Trump, he was also one of the first major political figures to advocate for legalized marijuana. It was no easy task... he failed six times to pass his pro-cannabis bill. He told me that, as a Republican, it was near impossible to make any movement on [legal cannabis](. He tried several different methods over his decades in Congress, but Republicans were “too scared of the far-right Christian Conservatives and losing their primaries” to agree to common-sense cannabis laws. 30-Fold Profits With Crypto Set to Dominate China A single cryptocurrency is perfectly positioned to dominate the soaring Chinese demand for crypto. And dominating the Chinese market for crypto means massive profits for investors. The team behind this crypto is local to China. They speak Mandarin. They’re experts at finding their way through the thicket of Chinese government regulations that often frustrate foreign businesses. This super crypto can perform thousands of business applications Bitcoin cannot dream of handling. Yet, it is tremendously undervalued, with about 1/30th of Bitcoin’s market cap. [Discover this super crypto in our free video.]( Even talking about the struggles he had during his advocacy made him visibly angry. Rep. Rohrabacher was clearly way ahead of his time. He told me that it was an inalienable right for Americans to be free to do as they wished as long as it didn't impede on others to do the same. He told me that the government should not be standing in the way of Americans' right to safe and effective medicine. He told me that throwing people in jail for "smoking a weed" simply ruined the lives of millions of Americans and wasted billions in tax money and pulled law enforcement away from actual crimes like murder, rape, and theft. But after repeated failures, he didn't give up. He came up with an ingenious plan... He tied medical marijuana to states' rights. Republicans backed states' rights in practically every other issue known to man. It worked. "I had no votes when I tried it before. Once I introduced states' rights into the argument, I immediately had 68 Republican votes." The Rohrabacher–Farr amendment passed in 2014, and has protected medical cannabis companies from being raided by the federal government ever since. It was the very first time that the House or the Senate voted to protect medical cannabis patients. But it was only the first shot fired in the battle to legalize cannabis countrywide. Many other shots will be fired this year, and I believe 2019 will be the year that the war is officially over… The encouraging thing is that the bills being put forth by Congress this year are very bipartisan. While Washington cannot seem to agree on anything else, it looks like marijuana may be the one issue that they can cross the aisle on… Who would have guessed? [How The Merck Of Marijuana Could Earn You 11,678%]( The hunt is finally over. I’ve delivered 429%, 380%, even 1,835% returns on legal marijuana. But the real money won’t roll in until pot cracks the $978 billion pharmaceutical industry. For months, I’ve been looking for the “category killer” in this rapidly emerging sector — the stock that would become the Bayer, Pfizer, or Merck of marijuana. Now I’m happy to say [I’ve found it.]( I firmly believe early investors could see 11,678% returns. [Watch This Video Briefing For All The Details.]( First up is the CARERS Act. The bill would require the federal government to allow states to legalize and regulate their own medical marijuana markets. More importantly, it would allow the U.S. Department of Veterans Affairs to issue medical marijuana recommendations for its patients, which it hasn’t been able to do in the past. In fact, Rep. Rohrabacher told me that was one of the reasons he was so steadfast in his support. One of his constituents — “a hard-line conservative” — came into his office. Rohrabacher thought that he was going to take him to task for pushing legal marijuana. It was the opposite — the man had a son who served in Iraq and came back with serious health problems. Despite it being illegal, a VA doctor gave him information on [medical cannabis](. The veteran took his advice and his physical and mental health completely rebounded. The voter vigorously thanked Rohrabacher for helping advance his son’s recovery. [It’s the Mother of All Arms Races!]( Russia and China have placed offensive weapons in space. We never did. Now we’re rushing to play catch-up. Making money may never be this easy again. [Click here to see how you could capture a 2,395% gain as soon as next year!]( The CARERS Act, sponsored by Steve Cohen (D-Tenn.) and Don Young (R-Alaska), would also expand marijuana research and give VA doctors the power to recommend cannabis treatment for veterans. That would be a game changer, not only for our veterans, but for the medical marijuana community at large… The second big bill to hit Congress this year is the “Regulate Marijuana like Alcohol Act” — which has the rather sophomoric title of "H.R.420". To tie this all together, the bill is sponsored by Democratic Rep. Earl Blumenauer of Oregon — who took over as co-sponsor of the Rohrabacher–Farr amendment after Sam Farr retired. The bill would remove cannabis from the federal Controlled Substances Act, which would remove the single biggest hurdle that faces cannabis today. Right now, marijuana is still federally illegal. Cannabis is categorized as a Schedule I substance, which means that it has “high abuse potential, no medical use, and severe safety concerns.” That means that marijuana is lumped in with dangerous drugs like heroin, LSD, and cocaine. If H.R.420 passes, both recreational and medical [cannabis companies]( will be free to conduct business without the fear of federal crackdowns. That means institutional money can begin flowing into the investment space. That means companies can finally tap into the U.S. banking system that they are currently frozen out of. Most importantly — from my perspective — it means that serious, large-scale clinical trials can begin on medical marijuana. Breakthrough CBD drugs will be developed. Americans will have access to low-cost, side effect-free medicines for conditions ranging from insomnia to cancer. I believe that once medical marijuana is treated like any other pharmaceutical drug, we’ll be kicking ourselves for not recognizing it sooner. One company I'm following is already well on its way to developing CBD drugs for cancer and heart disease. It will be well served when these bills come to pass. [You can read about its breakthrough research here](. To close, I'm very thankful we had civil servants like Republican Dana Rohrabacher to fire the first shot, and Democrat Earl Blumenauer to peacefully end the war. While it hasn't always been politically popular, without representatives like these, we would still be years away from making a serious difference in people's lives and freedoms. Godspeed, [Jimmy Mengel] Jimmy Mengel [follow basic]( [@mengeled on Twitter]( Jimmy is a managing editor for [Outsider Club]( and the investment director of the personal finance advisory, [The Crow's Nest,](and cannabis stocks advisory, [The Marijuana Manifesto.]( For more on Jimmy, check out his editor's [page](. *Follow Outsider Club on [Facebook]( and [Twitter](. Enjoy reading this article? [Click here]( to like it and receive similar articles to read! Browse Our Archives [Cannabis Stocks: Mergers, Acquisitions, and Pension Funds]( [America's Greatest Challenge Lies Immediately Ahead]( [The Top Commodity For The Long Haul]( [A New Uranium Bull Market?]( [The Race For Moon Riches]( --------------------------------------------------------------- This email was sent to {EMAIL}. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here](, and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Outsider Club, please add newsletter@outsiderclub.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. [Outsider Club](, Copyright © 2019, [Angel Publishing LLC]( & Outsider Club LLC, 111 Market Place #720, Baltimore, MD 21202. For Customer Service, please call (877) 303-4529. All rights reserved. [View our privacy policy here.]( No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned. Angel Publishing and Outsider Club does not provide individual investment counseling, act as an investment advisor, or individually advocate the purchase or sale of any security or investment. Subscribers should not view this publication as offering personalized legal or investment counseling. Investments recommended in this publication should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company in question. This letter is not intended to meet your specific individual investment needs and it is not tailored to your personal financial situation. Nothing contained herein constitutes, is intended, or deemed to be – either implied or otherwise – investment advice. Neither the publisher nor the editors are registered investment advisors. This letter reflects the personal views and opinions of Nick Hodge and that is all it purports to be. While the information herein is believed to be accurate and reliable it is not guaranteed or implied to be so. Neither Nick Hodge, nor anyone else, accepts any responsibility, or assumes any liability, whatsoever, for any direct, indirect or consequential loss arising from the use of the information in this letter. The information contained herein is subject to change without notice, may become outdated and may not be updated. Nick Hodge, entities that he controls, family, friends, employees, associates, and others may have positions in securities mentioned, or discussed, in this letter. No part of this letter/article may be reproduced, copied, emailed, faxed, or distributed (in any form) without the express written permission of Nick Hodge or the Outsider Club. Unauthorized reproduction of this newsletter or its contents by Xerography, facsimile, or any other means is illegal and punishable by law.